Incontinentia Pigmenti: A Case Report of a Complex Systemic Disease

Incontinentia Pigmenti is an uncommon X-linked genodermatosis, caused by mutations in the NEMO gene. It is a systemic disease that involves tissue of ectodermic and mesodermic origin, including cutaneous tissue, teeth, eyes and the central nervous system, amongst other organs. The Authors report a rare case of Incontinentia Pigmenti in a female newborn.


Introduction
First described by Bloch in 1926, and Sulzberger in 1928, incontinentia pigmenti (IP) is a rare X-linked genodermatosis [1,2], which name is related to the histological characteristics of the lesions in the third stage (or pigmentary stage) of the disease (Tab.1), consisting in the melanin incontinence by melanocytes of the basal epidermal layer and by its presence in the superficial dermis.
IP is a systemic disease which involves tissues of both ectodermic and mesodermic origin, including cutaneous tissue, teeth, eyes and the central nervous system, amongst other organs [3]. It is a hereditary, X-linked dominant disorder, with high penetrance and variable expressivity. It derives by mutations in the NEMO/IKKγ/IKBKG gene, located on Xq28. NEMO is the essential modulator of NF-kB, a transcriptor factor involved in immune and inflammatory responses, and in protecting cells from tumour necrosis factor-induced apoptosis. Disruption of the NEMO gene leads to diminish the NF-kB activity and to increase the cells susceptibility to apoptosis [4,5]. Also, inflammatory reactions and epidermal eosinophil recruitment, observed in the first stages of IP, seems to be important in the pathogenesis of the disease. It seems possible that the epidermal eosinophil accumulation is related to an eosinophil-selective chemokine (eotaxin), produced by specific leucocytes (e.g. eosinophils, macrophages, Tcells) and some structural cells (e.g. endothelial cells, fibroblasts and epithelial cells) [6].
In male patients, NEMO mutation is linked to their embryonic lethality. Female survival is due to the lyonization phenomenon (or X chromosome inactivation), which occur during early embryogenesis.
Although its epidemiological data are unknown, IP seems to occur in approximately 1 in 40.000 newborns [7]. About 50% of the IP cases have a positive family history of the same disease. The disease is predominant in women (F: M = 37:1). Less than 3% of cases are described in males. Many of them have Klinefelter's syndrome (47, XXY http://www.mjms.mk/ http://www.id-press.eu/mjms/ karyotype), where the second X chromosome seems to play an important role in their survival from the natural intrauterine death. In the other male cases, different genetic mutations have also been described, such as hypomorphic alleles or somatic mosaicism for the common IKBKG deletion [8,9].

Case report
A newborn female, 20 days old, affected by a diffuse vesciculo-bullous rash showed up to our Clinic (Fig. 1).
The baby was born at term by a spontaneous vaginal delivery, which was carried out after 3 hours by the membranes rupture.
The entire pregnancy had taken place regularly, without any complication. The patient's mother was an otherwise healthy single woman of 31 years old. She did not have previous pregnancies or abortions. During her childhood, the woman had suffered from varicella, rubeola, parotitis and rubella.
The woman told us to be affected by epilepsy. Her medical treatment, also during the pregnancy, consisted of carbamazepine. No other diseases or drugs assumptions had been reported. Her familial history was insignificant.
At the mother's clinical evaluation we did not observe any form of cutaneous, nail or hair alterations. Maternal serology was negative for VDRL, HIV, HBV, HCV.
Unfortunately, no news about the newborn's father had been reported to us. During the clinical evaluation, the young patient was 48 cm in height, and 2.6 kg of weight, which is less than normal. She had normal blood pressure, pulse rate and breathing. The musculoskeletal system was normal, except for an hypoplastic mandible. She did not have ocular or abdominal alterations.
From birth, the newborn suffered from seizures. The EEG showed a severely abnormal pattern with frequent multi-focal spikes; the head ultrasound showed a pattern of immature neurological development (Fig. 2). Even if, in a first moment, the neurologist thought how seizures could be the result of the carbamazepine abstinence, seizures never stopped as they were a primary disease.
During the dermatologic examination, we observed clear, tense blister and bullae, on inflammatory base. Lesions were localised on the extremities and the trunk, in a linear arrangement which followed the lines of Blaschko, and seemed to be asymptomatic. The Nikolsky test was negative. No other lesions were observed in the other cutaneous or mucosal areas.
Hairs were less than normal, wiry and coarse. Nails were dystrophic.
Routine blood testing for inflammation, infections and autoimmune diseases were negative, except for a peripheral eosinophilia (> 20%). Creactive protein and procalcitonin were normal. A punch biopsy performed on a lesion showed, in the epidermis, a mild acanthosis, foci of eosinophilic spongiosis and occasional dyskeratotic keratinocytes. In the same time, the dermis showed an infiltrate of lymphocytes, eosinophils and nuclear dust derived from eosinophilic karyorrhexis (Fig. 3).

Discussion
The clinical presentation of IP varies considerably, even among the family members of the same patient [10]. They range from subtle cutaneous and dental involvement to a complex syndrome, sometimes deadly.
Although IP may affect many organs, the cutaneous manifestations are the most commonly described (l). Typically the cutaneous lesions occur along the Blaschko's lines and evolve through four stages (Table 1) [11][12][13].
The first one (bullous stage) is described in 90% of patients at birth or within the first two weeks of life. Sometimes, it may occur in utero and doesn't progress after birth. Clinically, it is characterised by clear, tense bullae on inflammatory bases. Lesions are mainly described on the extremities (linear pattern) and the trunk (linear or circumferential pattern). Even if the face is usually spared, scalp lesions are quite common. The rash disappears by the age of 18 months. Recurrences can seldom be observed, also several years after the neonatal period, but they are usually shorter and less severe than the original eruption. The second stage (verrucous one) is characterised by a hypertrophic, wart-like rash, with the same localisation of initial lesions. Usually, stage 2 starts between the second and sixth weeks of life and persists for a few months. The third stage (hyperpigmentation stage) is the most characteristic one. It usually begins at the age sixtwelve months and persists into the adulthood. Clinically, it is characterised by brownish linear and whorled streaks which follow the Blaschko's lines. The pigmentation ranges in colour from blue-grey or slate to brown. The bizarre splashed or Chinese figure distribution is diagnostic. Linear or macular telangiectasia may also be described. The last stage (fourth stage or atretic one) is described only in 14 % patients. Clinically, it is characterised by hypo pigmentary and atrophic lesions, in the same areas of the previous hyperpigmentation. Melanin incontinence by melanocytes in the basal epidermal layer and its presence in the superficial dermis.
Epidermal atrophy and decreased, normal or small melanocytes. Skin appendages may be absent.
In realty, the onset and duration of each stage vary among individuals, and not all individuals experience all four stages. Stage 1 and three are more commonly observed than stage 2 and 4. Some patients may show additional cutaneous manifestations such as palmoplantar hyperhidrosis, port wine stain, abnormalities of mammary tissue, hair http://www.mjms.mk/ http://www.id-press.eu/mjms/ (e.g. alopecia, woolly hair) and nails alterations (e.g. onycho-dystrophy, onychogryphosis, pitting, yellow discoloration, subungual and periungual keratotic tumours) [14,15]. Extracutaneous manifestations may also be described.
Also, immunologic abnormalities are common in IP. They include functional abnormalities of neutrophils and lymphocytes and defects in polymorphonuclear chemotaxis. Eosinophilia up to 50% in the peripheral blood is common in the first inflammatory stage of IP.
Unfortunately, to date, no strict diagnostic criteria for IP exist. The diagnosis is mainly clinical, and it is based on recognition of the typical cutaneous lesions. The presence of dental, hair, nails and ocular alterations support the diagnosis. Peripheral eosinophilia is a suggestive sign in the earlier diagnosis. Eventually, a family history of X-linked inheritance or a history of multiple miscarriages may also support the hypothetic diagnosis.
The diagnosis may be confirmed only with the histological examination of a skin biopsy, and molecular genetic test (NEMO mutation).
In conclusion, because IP is a systemic disorder, a multidisciplinary approach to the patients is crucial. A complete neurologic examination is recommended for all IP infants. Regular visits to a paediatric ophthalmologist are essential during the first year of life. Laser photocoagulation and vascular endothelial growth factor inhibitor seem to be good treatments for retinal vascular abnormalities [22].
Concerning teeth, a radiologic evaluation and dental intervention by the age of two years is an appropriate therapeutic approach.
The dermatological management in the newborn period is aimed at reducing the risk of infection of blisters using antibiotics and hygienic preventive measures. Spontaneous improvement and resolution of skin lesions is general the rule. Topical and systemic steroids may be prescribed to limit the rash of the first two stages [23]. The use of laser therapies to treat the hyperpigmented lesions of should be discouraged because it has been reported to trigger an extensive vesicular-bullous eruption [24].